TABLE 1

Metabolite pattern in plasma, urine, bile, and feces after subcutaneous administration of 30 μg [3H]1-degarelix/kg in rats (rat study R1)

GenderSampleSampling PeriodPercentage of Component in Samplea
[3H]1-DegarelixFE 200486 (1–4)-OHFE 200486 (1–6)-OHFE 200486 (1–5)-OHFE 200486 (1–9)-OHFE 200486 (1–7)-OHUUFE 200486 (1–10)-OH
h
MalePlasma0–2487.412.6
Urineb0–4896.40.440.170.320.170.53
Bileb0–4817.225.930.51.179.9813.3
Fecesb0–485.8425.719.212.915.53.9014.4
FemalePlasma0–2494.35.75
Urineb0–4892.42.972.970.070.170.120.64
Bile0–4828.324.923.41.367.9114.1
Fecesb0–485.9526.612.09.9515.23.1524.7
  • U, unknown.

  • a Numbers represent mean values of four individual animals.

  • b Radioactivity detected in void peak adds up to 100%.